We are live on ! Find out more
DnB Asset Management

DnB Asset Management Portfolio holdings

AUM $28B
1-Year Est. Return 26%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+26%
3 Year Est. Return
+97.1%
5 Year Est. Return
+115.87%
10 Year Est. Return
+443.63%
AUM
$13.7B
AUM Growth
+$2.29B
Cap. Flow
+$1.38B
Cap. Flow %
10.11%
Top 10 Hldgs %
35.81%
Holding
662
New
38
Increased
482
Reduced
105
Closed
29

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$288M
2
GILD icon
Gilead Sciences
GILD
+$78.9M
3
WDC icon
Western Digital
WDC
+$69.8M
4
PFE icon
Pfizer
PFE
+$47.3M
5
BABA icon
Alibaba
BABA
+$46.5M

Sector Composition

Rank Sector Weight
1 Technology 30.66%
2 Communication Services 16.71%
3 Financials 14.36%
4 Healthcare 10.58%
5 Consumer Discretionary 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
601
DELISTED
Aerie Pharmaceuticals
AERI
$253K ﹤0.01%
14,129
-90,073
-86% -$1.56M
AZUL
602
DELISTED
Azul
AZUL
$238K ﹤0.01%
11,806
+991
+9% +$21.6K
AES icon
603
AES
AES
$10.6B
-20,947
Closed -$492K
APLS
604
DELISTED
Apellis Pharmaceuticals
APLS
-36,913
Closed -$2.11M
BLUE
605
DELISTED
bluebird bio
BLUE
-838
Closed -$470K
CELH icon
606
Celsius Holdings
CELH
$7.44B
-44,130
Closed -$740K
COHR icon
607
Coherent
COHR
$43.6B
-28,978
Closed -$2.2M
DAN icon
608
Dana Inc
DAN
$2.89B
-147,150
Closed -$2.87M
FOLD
609
DELISTED
Amicus Therapeutics
FOLD
-15,728
Closed -$363K
HBI
610
DELISTED
Hanesbrands
HBI
-18,200
Closed -$265K
IGMS
611
DELISTED
IGM Biosciences
IGMS
-12,280
Closed -$1.08M
ITRI icon
612
Itron
ITRI
$4.52B
-26,929
Closed -$2.58M
JKS
613
JinkoSolar
JKS
$773M
-25,936
Closed -$1.6M
LOOP icon
614
Loop Industries
LOOP
$35.3M
-41,686
Closed -$345K
MGA icon
615
Magna International
MGA
$18.9B
-85,887
Closed -$6.08M
RIGL icon
616
Rigel Pharmaceuticals
RIGL
$715M
-14,337
Closed -$502K
VIAV icon
617
Viavi Solutions
VIAV
$7.82B
-2,630,357
Closed -$39.4M
VSTA
618
DELISTED
Vasta Platform
VSTA
-29,199
Closed -$423K
XPEV icon
619
XPeng
XPEV
$12.5B
-33,156
Closed -$1.42M
YMAB
620
DELISTED
Y-mAbs Therapeutics
YMAB
-22,559
Closed -$1.12M
KLRS
621
Kalaris Therapeutics
KLRS
$78.8M
-1,306
Closed -$1.15M
FTCH
622
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-11,204
Closed -$715K
EPZM
623
DELISTED
Epizyme, Inc
EPZM
-20,744
Closed -$225K
VNE
624
DELISTED
Veoneer, Inc.
VNE
-760,275
Closed -$16.2M
GLUU
625
DELISTED
Glu Mobile Inc.
GLUU
-3,540,960
Closed -$31.9M

Similar funds

DnB Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, DnB Asset Management held 662 positions worth $13.7B, up 20% from $11.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

DnB Asset Management deployed $1.38B of net new capital in Q1 2021, opening 38 new positions and adding to 482 existing holdings. Its largest new stake was Baidu: 192,672 shares worth $41.9M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Oracle, an estimated $288M trimmed.

  • DnB Asset Management's largest Q1 2021 buy was Baidu: 192,672 shares worth $41.9M.
  • DnB Asset Management added most to Microsoft in Q1 2021, an estimated $295M increase.
  • DnB Asset Management's biggest Q1 2021 reduction was Oracle, cutting an estimated $288M.
  • DnB Asset Management fully exited Viavi Solutions in Q1 2021, selling an estimated $39.4M.
  • DnB Asset Management's ten largest holdings make up 36% of its $13.7B portfolio in Q1 2021.
  • DnB Asset Management opened 38 new positions and closed 29 in Q1 2021.
  • DnB Asset Management's portfolio value rose 20% quarter-over-quarter to $13.7B.

Based on DnB Asset Management's 13F filing for Q1 2021, filed 15 Apr 2021.